glp 1 aspiration risk GLP-1 RAs slow gastric emptying (gastroparesis-like effect) — a primary pharmacological GLP-1 receptor agonists and surgical

Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice

Convenient patch format for all-day support

Immunovant announces IMVT-1402, a next generation Anti-FcRn [press release]

If you realize youve taken ibuprofen with a potentially interacting medication, monitor for symptoms like bleeding or dizziness and contact your healthcare provider immediately

Now, two new late-phase clinical trials, sponsored by Eli Lilly and Company, suggest that transitioning from high dose injectable weight loss medications to either a daily pill or a lower maintenance dose can help people living with obesity to keep off most of the weight they have already lost The results of the ATTAIN-MAINTAIN and SURMOUNT-MAINTAIN trials were presented at the European Congress on Obesity and published in Previous research suggests that 1 year after stopping weight loss medication, people may regain, on average, 60% of their lost weight

No one really knows